Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Disorder Neonatal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03513328
What this trial is testing

Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation

Who this might be right for
Bone Marrow Failure SyndromeThalassemiaSickle Cell Disease+13 more
University of Florida 6
Not applicableStudy completedNCT04076306
What this trial is testing

What is the Feasibility of the ISTEP Exercise Test in Boys With Haemophilia

Who this might be right for
Hemophilia
Great Ormond Street Hospital for Children NHS Foundation Trust 43
Not applicableStudy completedNCT03299699
What this trial is testing

Quality of Life and Adjustment Among Siblings of Children and Adolescents With Severe Hemophilia

Who this might be right for
Severe Haemophilia
Assistance Publique Hopitaux De Marseille 30
Testing effectiveness (Phase 2)Study completedNCT03588299
What this trial is testing

Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle"

Who this might be right for
Hemophilia A
Bayer 11
Testing effectiveness (Phase 2)Ended earlyNCT04541628
What this trial is testing

Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A

Who this might be right for
Hemophilia A
Eli Lilly and Company 3
Testing effectiveness (Phase 2)Study completedNCT00134004
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 210
Not applicableStudy completedNCT01436825
What this trial is testing

Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients

Who this might be right for
Haemophilia A
Bayer 69
Not applicableStudy completedNCT00212485
What this trial is testing

Study to Evaluate the Use of Ultrasound in the Diagnosis of Hemophilic Joint Disease

Who this might be right for
Inherited Bleeding Disorders
New York Presbyterian Hospital 43
Not applicableUnknownNCT01626105
What this trial is testing

Personalized Prediction of Tolerance and Immunogenicity in Hemophilia

Who this might be right for
Hemophilia A
Victor J Marder, M.D. 55
Not applicableUnknownNCT05439642
What this trial is testing

Validation and Reliability of the CHO-KLAT in Turkish

Who this might be right for
Hemophilia AHemophilia B
Yuzuncu Yil University 100
Testing effectiveness (Phase 2)Study completedNCT00245245
What this trial is testing

Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII

Who this might be right for
Hemophilia A
Octagen Corporation 12
Testing effectiveness (Phase 2)Study completedNCT00010283
What this trial is testing

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT02895945
What this trial is testing

BAX 802 in CHA With Inhibitors

Who this might be right for
Hemophilia A
Baxalta now part of Shire 8
Early research (Phase 1)Study completedNCT02994407
What this trial is testing

Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 50
Not applicableStudy completedNCT02540187
What this trial is testing

Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients

Who this might be right for
Hemophilia
Centre Hospitalier Universitaire de Saint Etienne 164
Not applicableStudy completedNCT02093741
What this trial is testing

ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)

Who this might be right for
Hemophilia ACongenital Factor VIII (FVIII) Deficiency
Baxalta now part of Shire 65
Not applicableStudy completedNCT04675541
What this trial is testing

Register of Patients With haEmophilia A tReated With Afstyla®

Who this might be right for
Haemophilia A
CSL Behring 62
Large-scale testing (Phase 3)Study completedNCT01029340
What this trial is testing

Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A

Who this might be right for
Blood Coagulation DisordersHemophilia A
Bayer 74
Post-approval studies (Phase 4)Study completedNCT03379974
What this trial is testing

Exercise Versus DDAVP in Patients With Mild Hemophilia A

Who this might be right for
Hemophilia A
Nationwide Children's Hospital 32
Not applicableUnknownNCT02785718
What this trial is testing

The Proteins of the Contact Activation System

Who this might be right for
Factor XI DeficiencyFactor XII Deficiency
Hospices Civils de Lyon 18
Next Page